Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Espie

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
European Journal of Gynaecological Oncology|April 30, 2014
Contraception after breast cancer: a retrospective review of the practice among French gynecologists in the 2000'sA S Hamy, H Abuellellah, H Hocini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2013
Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancerJ Crown, M J Kennedy, P Tresca, et al.
Environmental Toxicology and Chemistry|February 16, 2018
Spatial trends in a biomagnifying contaminant: Application of amino acid compound-specific stable nitrogen isotope analysis to the interpretation of bird mercury levelsSvetlana Dolgova, Brian N Popp, Kevin Courtoreille, et al.
British Journal of Cancer|November 27, 2001
High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II studyP H Cottu, J M Extra, M Espie, et al.
Bulletin Du Cancer|May 28, 2009
[Sentinel node biopsy in breast cancer]E Hindié, D Groheux, M Espie, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2017
Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer studyX Pivot, J P Spano, M Espie, et al.
Evolution; International Journal of Organic Evolution|January 15, 2016
Life span and reproductive cost explain interspecific variation in the optimal onset of reproductionEmeline Mourocq, Pierre Bize, Sandra Bouwhuis, et al.
Trends in Ecology & Evolution|September 29, 2015
Archiving Primary Data: Solutions for Long-Term StudiesJames A Mills, Céline Teplitsky, Beatriz Arroyo, et al.
Trends in Ecology & Evolution|January 19, 2016
Solutions for Archiving Data in Long-Term Studies: A Reply to Whitlock et alJames A Mills, Céline Teplitsky, Beatriz Arroyo, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
European Journal of Gynaecological Oncology|April 30, 2014
Contraception after breast cancer: a retrospective review of the practice among French gynecologists in the 2000'sA S Hamy, H Abuellellah, H Hocini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2013
Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancerJ Crown, M J Kennedy, P Tresca, et al.
Environmental Toxicology and Chemistry|February 16, 2018
Spatial trends in a biomagnifying contaminant: Application of amino acid compound-specific stable nitrogen isotope analysis to the interpretation of bird mercury levelsSvetlana Dolgova, Brian N Popp, Kevin Courtoreille, et al.
British Journal of Cancer|November 27, 2001
High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II studyP H Cottu, J M Extra, M Espie, et al.
Bulletin Du Cancer|May 28, 2009
[Sentinel node biopsy in breast cancer]E Hindié, D Groheux, M Espie, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2017
Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer studyX Pivot, J P Spano, M Espie, et al.
Evolution; International Journal of Organic Evolution|January 15, 2016
Life span and reproductive cost explain interspecific variation in the optimal onset of reproductionEmeline Mourocq, Pierre Bize, Sandra Bouwhuis, et al.
Trends in Ecology & Evolution|September 29, 2015
Archiving Primary Data: Solutions for Long-Term StudiesJames A Mills, Céline Teplitsky, Beatriz Arroyo, et al.
Trends in Ecology & Evolution|January 19, 2016
Solutions for Archiving Data in Long-Term Studies: A Reply to Whitlock et alJames A Mills, Céline Teplitsky, Beatriz Arroyo, et al.
Pageof 5